...at Bayer AG and later at German startup Nadag AG, which was subsequently acquired by Sirenade Pharmaceuticals AG...

...CombinatoRx IPO 11/9/05 $155.0 GlycArt M&A (Roche) 7/19/05 $181.5 KuDos (A) M&A (AstraZeneca) 12/23/05 $210.0 Sirenade...

...Sirenade Pharmaceuticals AG , Munich, Germany Business: Neurology, Cancer, Supply/Service KeyNeurotek acquired Sirenade for an undisclosed sum. Sirenade...

...Unwinding Last week, Germany's DVC saw exits for two of its portfolio companies. CNS company Sirenade...
...modest sum of low two-digit millions can be raised through a secondary offering on FSE." Sirenade's...

...Neurology company KeyNeurotek (Magdeburg, Germany) acquired Sirenade (Munich, Germany). Sirenade , which was founded in 2003...

...prevent or to destroy the plaques that typically accumulate in the brains of AD patients. Sirenade Pharmaceuticals AG...
...with the degradation of tau (see BioCentury, Aug. 27, 2001) . "As a result," said Sirenade...
...should make sense to combine targeting of beta amyloid deposits with strategies for eliminating NFTs." Sirenade...

...Data were presented at the International Conference on Alzheimer's Disease and Related Disorders in Philadelphia. Sirenade Pharmaceuticals AG...

...Neurology company Sirenade (Martinsried, Germany) hired Lynn Butler as CEO. Butler, who previously was director of...